Owlstone Medical announces key study results on use of Breat

Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced the results of a patient study that successfully demonstrates the use of exhaled limonene as a breath biomarker to measure liver function and stage liver disease.

Related Keywords

Austria , United States , United Kingdom , Cambridge Bioresource , Billy Boyle , Chrisa Mayhew , Institute For Breath Research , Cambridge Centre Early Detection Programme , University Of Birmingham , University Of Innsbruck , Cancer Research United Kingdom , Cambridge University Hospitals , International Alliance For Cancer Early Detection , Owlstone Medical , Nonalcoholic Fatty Liver Disease , Breath Biopsy , Generally Recognized , Molecular Physics , Breath Research , Victoria Snowdon , Transplant Hepatology , Centre Early Detection Programme , International Alliance , Cancer Early , Biopsy , Liver , Liver Disease , Biomarker , Dancer , Arcinoma , Cirrhosis , Compound , Iagnostic , Fatty Liver , Astroenterology , Medicine , Precision Medicine , Research ,